4.6 Review

Food as medicine: targeting the uraemic phenotype in chronic kidney disease

Journal

NATURE REVIEWS NEPHROLOGY
Volume 17, Issue 3, Pages 153-171

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41581-020-00345-8

Keywords

-

Funding

  1. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302034/2018-8]
  2. FundacAo de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/202.24/2019]
  3. Strategic Research Program in Diabetes at Karolinska Institutet (Swedish Research Council) [2009-1068]
  4. European Union's Horizon 2020 research and innovation Program under the Marie Skodowska-Curie grant [722609]
  5. International Network for Training on Risks of Vascular Intimal Calcification and roads to Regression of Cardiovascular Disease (INTRICARE)
  6. Baxter Healthcare

Ask authors/readers for more resources

The authors discuss how food and specific nutrients could affect the uraemic phenotype in chronic kidney disease (CKD). They suggest using a food-as-medicine approach to prevent and treat CKD. Unhealthy diets have been identified as a major risk factor for poor health outcomes, sparking interest in the concept of 'food as medicine', especially in metabolic diseases like CKD.
Here, the authors discuss the mechanisms by which food and specific nutrients could affect the uraemic phenotype in chronic kidney disease (CKD). They suggest that a food-as-medicine approach could potentially be used to prevent and treat CKD and its complications. The observation that unhealthy diets (those that are low in whole grains, fruits and vegetables, and high in sugar, salt, saturated fat and ultra-processed foods) are a major risk factor for poor health outcomes has boosted interest in the concept of 'food as medicine'. This concept is especially relevant to metabolic diseases, such as chronic kidney disease (CKD), in which dietary approaches are already used to ameliorate metabolic and nutritional complications. Increased awareness that toxic uraemic metabolites originate not only from intermediary metabolism but also from gut microbial metabolism, which is directly influenced by diet, has fuelled interest in the potential of 'food as medicine' approaches in CKD beyond the current strategies of protein, sodium and phosphate restriction. Bioactive nutrients can alter the composition and metabolism of the microbiota, act as modulators of transcription factors involved in inflammation and oxidative stress, mitigate mitochondrial dysfunction, act as senolytics and impact the epigenome by altering one-carbon metabolism. As gut dysbiosis, inflammation, oxidative stress, mitochondrial dysfunction, premature ageing and epigenetic changes are common features of CKD, these findings suggest that tailored, healthy diets that include bioactive nutrients as part of the foodome could potentially be used to prevent and treat CKD and its complications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available